| Asston Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 |
|---|---|---|---|---|
| Debt-Equity Ratio | 0.77 | 1.32 | 2.93 | 3.56 |
| Long Term Debt-Equity Ratio | 0.21 | 0.38 | 0.94 | 1.01 |
| Current Ratio | 1.74 | 1.37 | 1.04 | 0.97 |
| Fixed Assets | 21.77 | 13.41 | 6.14 | 10.21 |
| Inventory | 23.19 | 10.90 | 6.54 | 19.20 |
| Debtors | 1.21 | 1.27 | 0.87 | 1.50 |
| Interest Cover Ratio | 6.27 | 5.28 | 2.97 | 1.37 |
| PBIDTM (%) | 24.00 | 25.39 | 33.18 | 6.25 |
| PBITM (%) | 23.84 | 25.02 | 32.57 | 6.15 |
| PBDTM (%) | 20.21 | 20.65 | 22.17 | 1.77 |
| CPM (%) | 15.54 | 15.53 | 16.82 | 1.25 |
| APATM (%) | 15.38 | 15.16 | 16.21 | 1.15 |
| ROCE (%) | 36.73 | 37.65 | 36.93 | 13.75 |
| RONW (%) | 42.28 | 53.00 | 72.60 | 11.83 |